Reports from the Catalan Agency for Health Technology Assessment (CAHTA).
D000280:Administration, Inhalation; D005060:Europe; D006331:Heart Diseases / Q000628:therapy; D006801:Humans; D019458:Insurance Coverage; D009569:Nitric Oxide / Q000008:administration & dosage; D011655:Pulmonary Embolism / Q000188:drug therapy; D013030:Spain; D013673:Technology Assessment, Biomedical; D015912:Thrombolytic Therapy; D014665:Vasodilator Agents / Q000008:administration & dosage
D014665:Vasodilator Agents; D009569:Nitric Oxide